Scope of application of the ursodeoxycholic acid at gastroenterological pathology
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 2
Abstract
The article presents modern concepts on the using of ursodeoxycholic acid in the clinical practice of internist. The presented review is focused on the effects of ursodeoxycholic acid, the current spectrum of it’s application in the treatment of the patients with gastroenterological pathology, in particular, gastroesophageal reflux disease, non-alcoholic fatty liver disease, autoimmune hepatobiliary processes, chronic hepatitis, intestinal dysbiosis. The literature review has covered the historical data on the release of ursodeoxycholic acid, the first studies on the results of this drug using, and listed the ursodeoxycholic acid effects and scope of application. The literature review presents data from the global studies of the ursodeoxychloric acid effects on patients with the above listed nosology. The efficacy of its preparation has been proved in terms of reduction of the clinical manifestations of intrahepatic cholestasis in pregnant women without side effects. The presented data showed the survival prolongation in patients with primary biliary cholangitis against the background of ursodeoxychloric acid administration. It has been emphasized that long-term use of ursodeoxycholic acid at viral hepatitis, along with etiotropic therapy, allowed to eliminate the clinical manifestations and to avoid the development of complications. It was demonstrated that ursodeoxycholic acid has protective properties against the damaging effect of bile acids on the esophagus walls at gastroesophageal reflux disease. The data have been presented on the UCDA positive effects on the lipid spectrum in patients with non-alcoholic fatty liver disease. The data illustrating the significant positive differences in the composition and function of the microbiome after prolonged use of ursodeoxycholic acid have been outlined.
Authors and Affiliations
L. V. Zhuravlyova, O. V. Ogneva
Keywords
Related Articles
- EP ID EP575139
- DOI 10.30978/MG-2019-2-66
- Views 119
- Downloads 0
A place of plasma substitutes in the treatment of patients with chronic viral hepatitis
Objective — to assess the efficacy of plasma substitute (Reosorbilact) in patients with chronic viral hepatitis. Materials and methods. The investigation involved 60 patients with chronic viral hepatitis (CVH), who were...
Effects of L-ornithine-L-aspartate on the manifestation of minimal hepatic encephalopathy in the dynamics of cytostatic therapy
Objective — to investigate effects of the L-ornithine-L-aspartate (LOLA, Hepa-Merz®) on the clinical manifestations of minimal hepatic encephalopathy (HE) in patients with multiple myeloma (MM) in the dynamics of cytosta...
Fibrokolium in the treatment of irritable bowel syndrome with constipation: the first experience in Ukraine
Objective — to compare the clinical efficacy of Fibrokolium (Specchiasol S.r.l, Italy) with the drug psyllium in the treatment of patients with irritable bowel syndrome and constipations (IBS-C). Materials and methods....
The syndrome of increased intestinal permeability: a focus on microbiota
The literature data have been presented regarding the syndrome of increased intestinal permeability, the role of intestinal; dysbiosis in the development of the increased intestinal permeability and its effects on the de...
V Maastricht consensus: the personified approach to the eradication therapy with account of the regional peculiarities of Ukraine
The key provisions of the V Maastricht Consensus on the diagnosis and treatment of Helicobacter pylori infection have been considered. The analysis has been performed for the main results of eradication therapy for the l...